Nocturia

Global Nocturia Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 639 | Number of pages: 192 | Publish Date: Jul 2019 | Category: Lifesciences and Healthcare
Global Nocturia Market is valued at USD 2549.3 Million in 2018 and expected to reach USD 4397.4 Million by 2025 with a CAGR of 8.1% over the forecast period. Increasing geriatric population across the globally is anticipated to drive growth of Global Nocturia Market.

Scope of Nocturia Market Reports

Nocturia is the medical condition referred to the excessive urination at night. This is more common in the geriatric population and occurs in both men and women. Normally, during sleep time, human body produces less urine and that is more concentrated and most people don’t need to wake up during the night to urinate and can sleep uninterrupted for 6 to 8 hours. Its major causes include the range from lifestyle choices to medical conditions such as; sleep disorders, and bladder obstruction, infection or enlargement of the prostate, bladder prolapse, prostate, or pelvic area, tumors of the bladder, diabetes, anxiety, kidney infection, edema or swelling of the lower legs, obstructive sleep apnea, and neurological disorders, such as Parkinson’s disease, or spinal cord compression. It is also common in people with organ failure, such as heart or liver failure. It can be a symptom of a more serious condition, such as diabetes or a urinary tract infection which can worsen or spread if left untreated. It can be treated by certain activities, such as restricting fluids. There are also medications that reduce symptoms of overactive bladder. Global Nocturia Market report is segmented on the basis of drug type, indication type, distribution channel and region & country level. Based upon drug type, global nocturia market is classified into anticholinergic drugs, antispasmodic, antibiotics, desmopressin and others. Based upon indication type, global nocturia market is divided into mixed nocturia, low nocturnal bladder capacity, nocturnal polyuria and global polyuria. Based on distribution channel, the nocturia market is classified into retail pharmacies, hospital pharmacies and online pharmacies. The regions covered in this Nocturia Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of nocturia is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc. Key Players for Global Nocturia Market Report- Some major key players for Global Nocturia Market are Allergan, Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, AA Pharma, Avadel Pharmaceuticals and others. Increasing Geriatric Population Coupled with the Increasing Prevalence of Organ Failure, Such as Heart or Liver Failure Drives the Growth of Global Nocturia Market The major factor driving the growth of global nocturia market is increasing geriatric population coupled with the increasing prevalence of organ failure, such as heart or liver failure. For example; As per National Center for Biotechnology Information; There is relatively large number of comparative studies confirming strong correlation between aging and prevalence of nocturia. Prevalence of two or more voids per night in individuals in their twenties varies between 5-15 %, it progresses with age, and in the seventh decade of life ranges between 35-50 %. In addition, increasing cases of hypertension are also anticipated to drive the growth of global nocturia market. For example; As per a new study conducted in Japan found that the need to urinate in the night, called nocturia, may be linked to hypertension and high salt intake. The study showed that getting up in the night to urinate was associated with a 40 percent greater chance of having high blood pressure, and the risk of hypertension rose significantly as the number of nocturia events per night increased. Furthermore, increasing awareness about the nocturia and improving healthcare infrastructure are also supplementing the growth of the market. However, high operational cost may hamper the market growth. In spite of that, increasing advancements in the field of drug delivery systems can provide various opportunities for the further growth of the market. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Nocturia Market. Key Benefits for Nocturia Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape. • and competitive landscape.

Global Nocturia Market Segmentation:

By Drug Type: • Anticholinergic Drugs • Antispasmodic • Antibiotics • Desmopressin • Others By Indication Type: • Mixed Nocturia • Low Nocturnal Bladder Capacity • Nocturnal Polyuria • Global Polyuria By Distribution Channel: • Retail Pharmacies • Hospital Pharmacies • Online Pharmacies By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America is Expected to Dominate the Global Nocturia Market The Global Nocturia Market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global nocturia market within the forecast period attributed to the highly developed healthcare infrastructure and increasing cases of nocturia in this region. For example; As per the National Center for Biotechnology Information; Nocturia affects 50 million people in the United States, with 10 million actually diagnosed with nocturia but only 1.5 million receiving specific therapy for it. One in three adults older than age 30 make at least two trips to the bathroom every night, and about 70% of these individuals are bothered by this. Europe is projected to capture the second largest share of global nocturia market owing to the increasing geriatric population in this region. Asia Pacific is anticipated to witness a significant growth in global nocturia market owing to the increasing research and development for new and more effective treatments in this region. Nocturia Market Key Players: • Allergan • Urigen Pharmaceuticals • Ferring Pharmaceuticals • Glenmark Pharmaceuticals • Teva Pharmaceutical Industries • AA Pharma • Avadel Pharmaceuticals • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Nocturia Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Nocturia Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Nocturia Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Nocturia Market Overview: Quantitative Analysis
3.1. Global Nocturia Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Nocturia Market Revenue Market Share (%), 2014- 2025
3.3. Global Nocturia Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Nocturia Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Nocturia Market Analysis: By Drug Type
5. Chapter – Global Nocturia Market Analysis: By Indication Type
6. Chapter – Global Nocturia Market Analysis: By Distribution Channel
7. Chapter - Global Nocturia Market Analysis: By Manufacturer 
7.1. Global Nocturia Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Nocturia Market Share (%), by Manufacturer, 2018
7.3. Global Nocturia Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Nocturia Market Share (%), by Manufacturer, 2018
7.5. Global Nocturia Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Nocturia Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Nocturia Market: Regional Analysis
8.1. North America
8.1.1. North America Nocturia Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Nocturia Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Nocturia Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Nocturia Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Nocturia Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Nocturia Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Nocturia Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Nocturia Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Nocturia Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Nocturia Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Allergan
9.1.1. Overview
9.1.2. Financials
9.1.3. Product portfolio
9.1.4. Nocturia Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.5. Nocturia Sales Market Share (%), 2014 - 2018
9.1.6. Business strategy
9.1.7. Recent developments
9.2. Urigen Pharmaceuticals
9.3. Ferring Pharmaceuticals
9.4. Glenmark Pharmaceuticals
9.5. Teva Pharmaceutical Industries
9.6. AA Pharma
9.7. Avadel Pharmaceuticals
9.8. Others
10. Chapter – Market Research and Findings